Evidence map›Paper›PMID 34764821›Full record

ArticlePathology oncology research : POR2021

Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC.

Hongmei Zheng, Yue Ning, Yang Yang, Yuting Zhan, Haihua Wang, Qiuyuan Wen, Jinwu Peng, Songqing Fan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. New insights on anti-tumor immunity of CD8Journal of translational medicine · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hongmei ZhengDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Yue NingDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Yang YangDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Yuting ZhanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Haihua WangDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Qiuyuan WenDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Jinwu PengDepartment of Pathology, Xiangya Basic Medical School, Central South University, Changsha, China.
Songqing FanDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tumor MicroenvironmentAdenocarcinoma of Lungbeta CateninBiomarkers, TumorCarcinoma, Non-Small-Cell LungCase-Control StudiesCohort StudiesFemaleFollow-Up StudiesHumansLung NeoplasmsLymphocytes, Tumor-InfiltratingMaleMiddle AgedPrognosisSurvival Ratebeta CateninBiomarkers, TumorCTNNB1 protein, humanbiomarkerNSCLCtumor immunitytumor microenvironmentβ-catenin

Identifiers

PMID34764821
PMCPMC8575687
OpenAlexW3209450929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.